Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
Eligibility criteria
Qualifiers
US Veterans over the age of 18 years with physician-diagnosed
Documented hyperuricemia (SU >6.8 mg/dL)
Satisfy ACR/EULAR gout classification criteria
Report 1 or more flares in the prior 6 months
Disqualifiers
Any patient intolerant or unable to take ULTs (allopurinol or febuxostat)
Patients with a rheumatology encounter within the prior 3 months
Trial design
Treatments tested in this trial
- Pharmacist-Led
Treatment groups
310 Participants
are divided into 2 treatment groupsLocations
5Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE68105-1850, OmahaNebraska, United States
VA Portland Health Care System, Portland, OR97207-2964, PortlandOregon, United States
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA19104-4551, PhiladelphiaPennsylvania, United States
VA Salt Lake City Health Care System, Salt Lake City, UT84148-0001, Salt Lake CityUtah, United States
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
Source ClinicalTrials.gov